{"entity":{"type":"insider","cik":"0001491435","url":"/insider/0001491435","json_url":"/insider/0001491435.json","name":"HANTSON LUDWIG","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2012-09-27","last":"2019-01-03","span_basis":"filed_date"},"name_variants":[{"name":"HANTSON LUDWIG","source":"filing","n_filings":7,"first_seen":"2012-09-27","last_seen":"2019-01-03"}],"transactions":[{"id":8545281,"accession":"0000899866-19-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-19-000005","line_url":"/filing/0000899866-19-000005#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS, INC.","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3244.0,"shares_display":"3,244","price_per_share":95.85,"price_display":"95.85","price_state":"stated","total_value":310937.4,"total_display":"310,937.40","total_whole":"310,937","shares_owned_after":150696.0,"shares_owned_after_display":"150,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-31","filed_date":"2019-01-03","scope":"insider"},{"id":6408117,"accession":"0000899866-18-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-18-000036","line_url":"/filing/0000899866-18-000036#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13245.0,"shares_display":"13,245","price_per_share":116.31,"price_display":"116.31","price_state":"stated","total_value":1540525.95,"total_display":"1,540,525.95","total_whole":"1,540,526","shares_owned_after":118180.0,"shares_owned_after_display":"118,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider"},{"id":6063226,"accession":"0000899866-18-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000002","line_url":"/filing/0000899866-18-000002#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2553.0,"shares_display":"2,553","price_per_share":121.63,"price_display":"121.63","price_state":"stated","total_value":310521.39,"total_display":"310,521.39","total_whole":"310,521","shares_owned_after":36172.0,"shares_owned_after_display":"36,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4392284,"accession":"0000899866-17-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000144","line_url":"/filing/0000899866-17-000144#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":116.72,"price_display":"116.72","price_state":"stated","total_value":1167200.0,"total_display":"1,167,200.00","total_whole":"1,167,200","shares_owned_after":38725.0,"shares_owned_after_display":"38,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-19","scope":"insider"},{"id":6243858,"accession":"0001491435-14-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001491435-14-000005","line_url":"/filing/0001491435-14-000005","is_derivative":false,"issuer_cik":"0000010456","issuer_name":"BAXTER INTERNATIONAL INC","issuer_ticker":"BAX","issuer_name_source":null,"issuer_url":"/issuer/0000010456","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Officer (Corporate Vice President)","role_mark":"O","role_mark_label":"Officer (Corporate Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Vice President","security_title":"Common Stock, $1 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24693.0,"shares_display":"24,693","price_per_share":76.0,"price_display":"76.00","price_state":"stated","total_value":1876668.0,"total_display":"1,876,668.00","total_whole":"1,876,668","shares_owned_after":83903.0,"shares_owned_after_display":"83,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-09","filed_date":"2014-07-11","scope":"insider","n_lines":2},{"id":4661386,"accession":"0001491435-13-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001491435-13-000002","line_url":"/filing/0001491435-13-000002#line-1","is_derivative":false,"issuer_cik":"0000010456","issuer_name":"BAXTER INTERNATIONAL INC","issuer_ticker":"BAX","issuer_name_source":null,"issuer_url":"/issuer/0000010456","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Officer (Corporate Vice President)","role_mark":"O","role_mark_label":"Officer (Corporate Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Vice President","security_title":"Common Stock, $1 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":67.64,"price_display":"67.64","price_state":"stated","total_value":710220.0,"total_display":"710,220.00","total_whole":"710,220","shares_owned_after":87005.0,"shares_owned_after_display":"87,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-29","scope":"insider"},{"id":2103487,"accession":"0001491435-12-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001491435-12-000003","line_url":"/filing/0001491435-12-000003#line-2","is_derivative":false,"issuer_cik":"0000010456","issuer_name":"BAXTER INTERNATIONAL INC","issuer_ticker":"BAX","issuer_name_source":null,"issuer_url":"/issuer/0000010456","owner_cik":"0001491435","owner_name":"HANTSON LUDWIG","owner_display_name":"HANTSON LUDWIG","owner_url":"/insider/0001491435","role":"Officer (Corporate Vice President)","role_mark":"O","role_mark_label":"Officer (Corporate Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Vice President","security_title":"Common Stock, $1 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36059.0,"shares_display":"36,059","price_per_share":61.54,"price_display":"61.54","price_state":"stated","total_value":2219070.86,"total_display":"2,219,070.86","total_whole":"2,219,071","shares_owned_after":89652.0,"shares_owned_after_display":"89,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-25","filed_date":"2012-09-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS, INC.","url":"/issuer/0000899866","role":"Director, Officer (CEO)","n_filings":4,"first_seen":"2017-06-19","last_seen":"2019-01-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000010456","name":"BAXTER INTERNATIONAL INC","url":"/issuer/0000010456","role":"Officer (Corporate Vice President)","n_filings":3,"first_seen":"2012-09-27","last_seen":"2014-07-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001491435","retrieved_at":"2026-08-25T13:36:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}